Cargando…
Construction of a human monoclonal antibody against bFGF for suppression of NSCLC
Compelling evidence implicates that overexpression of basic fibroblast growth factor (bFGF) and fibroblast growth factor receptor 1 (FGFR1) in non-small cell lung cancer (NSCLC) drives tumor progression, can serve as prognostic biomarkers or therapeutic targets for NSCLC patients. But at present, we...
Autores principales: | Wang, Sheng, Qin, Yiyang, Wang, Zhongmin, Xiang, Junjian, Zhang, Yu, Xu, Meng, Li, Baiyong, Xia, Yu, Zhang, Peng, Wang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995934/ https://www.ncbi.nlm.nih.gov/pubmed/29896285 http://dx.doi.org/10.7150/jca.24255 |
Ejemplares similares
-
Production of bFGF monoclonal antibody and its inhibition of metastasis in Lewis lung carcinoma
por: Yang, Yanqing, et al.
Publicado: (2017) -
Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells
Publicado: (1994) -
Influence of bFGF on in vitro expansion and chondrogenic construction of articular cartilage-derived progenitor cells
por: Shen, Xu, et al.
Publicado: (2022) -
Metformin reverses bFGF-induced epithelial-mesenchymal transition in HCC cells
por: Chengye, Wang, et al.
Publicado: (2017) -
Expression of bFGF and VEGF in brain astrocytoma.
por: Shim, J. W., et al.
Publicado: (1996)